Scandinavian Working Papers in Economics
Discussion Paper Series in Economics,
Norwegian School of Economics, Department of Economics
No 20/2018: Quality Regulation and Competition: Evidence from Pharmaceutical Markets
Juan Pablo Atal (), José Ignacio Cuesta () and Morten Sæthre ()
Additional contact information
Juan Pablo Atal: University of Pennsylvania, Postal: University of Pennsylvania
José Ignacio Cuesta: University of Chicago, Postal: University of Chicago
Morten Sæthre: Dept. of Economics, Norwegian School of Economics and Business Administration, Postal: NHH , Department of Economics, Helleveien 30, N-5045 Bergen, Norway
Abstract: We study the effects of quality regulation on market outcomes by exploiting the staggered phase-in of bioequivalence requirements for generic drugs in Chile. We estimate that the number of drugs in the market decreased by 25%, average paid prices increased by 10%, and total sales decreased by 20%. These adverse effects were concentrated among small markets. Our results suggest that the intended effects of quality regulation on price competition through increased (perceived) quality of generics—and therefore reduced vertical differentiation—were overturned by adverse competitive effects arising from the costs of complying with the regulation.
Keywords: Quality regulation; competition; bioequivalence; generic pharmaceuticals
68 pages, September 26, 2018
Full text files
2566705Full text
Questions (including download problems) about the papers in this series should be directed to Karen Reed-Larsen ()
Report other problems with accessing this service to Sune Karlsson ().
RePEc:hhs:nhheco:2018_020This page generated on 2024-09-13 22:16:16.